VISFO
Knowledge base
Epidemiology
Lead a more targeted approach to drug development, testing and commercialization by understanding the size of your addressable patient population in terms of the incidence, prevalence and spread of disease.
Definition and criteria
A well-recognized, highly respected and trusted expert with significant influence in their field. KOLs are often thought leaders and educators, whose perceptions are likely to impact the opinions and decisions of others in their professional network. To be considered a KOL, an individual may fulfill some or even all of the following criteria:
Criteria 1
Lorem ipsum dolor sit amet.
Criteria 2
Lorem ipsum dolor sit amet.
Criteria 3
Lorem ipsum dolor sit amet.
Criteria 4
Criteria 5
Lorem ipsum dolor sit amet.
Criteria 6
Lorem ipsum dolor sit amet.
Power your decision-making
with bespoke and intuitive intelligence boards
Visualize
VISFO combines cutting-edge technology and deep subject matter expertise to de-silo data and enable confident decision-making. With all outputs housed in our fully interactive, AI-enhanced knowledge base. Teams can drill down from high-level strategy to granular evidence, surfacing the right information in seconds.
Identify
- Disease prevalence and incidence
- Disease risk factors
- Mortality and morbidity rates
- Surveillance trends
- Population demographics
Analyze
- Insights at a regional, state, or country level
- Demographic trends and disparities within, e.g., different age, sex, race and ethnicity categories
- Disease causation and comorbidity relationships, aided by filters for disease etiology and risk factors
Maintain a clear view of the dynamics of disease distribution over the entire lifecycle of your product with user-defined data updates.
Prevalence of non-alcoholic steatohepatitis (NASH) since 2012
Use cases
How can this help your team...
Medical Affairs
Leverage real-world evidence (RWE) to complement clinical trial data, evaluate treatment effectiveness in real-world settings and inform clinical decision-making
Develop educational materials about disease prevalence, risk factors and treatment options
Support scientific communications and publications
Market Access
Estimate the market size for a new therapy to assess commercial opportunity
Tailor access strategies, justify pricing decisions and negotiate reimbursement agreements
Inform Health Economics and Outcomes Research (HEOR)
Clinical Development
Determine the size and characteristics of the patient population most likely to benefit from an intervention
Select clinically relevant endpoints, outcome measures and comparators for clinical trials
Facilitate clinical trial recruitment by identifying regions or populations with high disease prevalence
See it in action with an interactive demo
See how VISFO’s precision intelligence and collaborative approach ensures you have the right insights, at the right time, to make the best possible strategic decisions.
